Zacks Investment Research Lowers VWR Corporation (VWR) to Hold
VWR Corporation (NASDAQ:VWR) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a note issued to investors on Thursday.
According to Zacks, “VWR’s second-quarter earnings report was quite impressive, with both the top and the bottom line beating the Zacks Consensus Estimate. Geographically, the company recorded growth in Americas during the reported quarter driven by strong sales of equipment and instrumentation. Management is also looking forward to the long-term synergy benefits from the proposed merger with Avantor. The merger is expected to strengthen VWR’s business across the Americas and Europe. While we await the merger to close in the fourth quarter of 2017 we note that the stock price has already reached close to Avantor’s offer price and hence the short-term upside potential of VWR is limited now. On the flip side, a drop in EMEA-APAC sales was disappointing. Moreover, foreign currency was a major dampener. VWR’s poor margin scenario also raises concern.”
A number of other equities analysts have also recently issued reports on VWR. BidaskClub upgraded VWR Corporation from a “strong sell” rating to a “sell” rating in a report on Friday, August 11th. ValuEngine upgraded VWR Corporation from a “hold” rating to a “buy” rating in a report on Wednesday, September 6th. One research analyst has rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the stock. VWR Corporation currently has an average rating of “Hold” and an average price target of $31.67.
VWR Corporation (NASDAQ:VWR) traded up 0.03% during mid-day trading on Thursday, reaching $33.19. The company’s stock had a trading volume of 1,008,327 shares. The company has a market cap of $4.38 billion, a price-to-earnings ratio of 30.73 and a beta of 1.18. The stock’s 50 day moving average is $33.08 and its 200 day moving average is $31.87. VWR Corporation has a 12 month low of $24.42 and a 12 month high of $37.25.
VWR Corporation (NASDAQ:VWR) last issued its earnings results on Monday, July 31st. The medical research company reported $0.49 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.45 by $0.04. VWR Corporation had a return on equity of 15.54% and a net margin of 3.12%. The firm had revenue of $1.18 billion for the quarter, compared to analysts’ expectations of $1.16 billion. During the same quarter last year, the business earned $0.42 earnings per share. The company’s revenue was up 2.2% compared to the same quarter last year. Equities research analysts predict that VWR Corporation will post $1.86 EPS for the current year.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Amalgamated Bank raised its position in shares of VWR Corporation by 1.7% during the first quarter. Amalgamated Bank now owns 11,202 shares of the medical research company’s stock worth $316,000 after purchasing an additional 183 shares during the period. Neuberger Berman Group LLC raised its position in shares of VWR Corporation by 3.0% during the second quarter. Neuberger Berman Group LLC now owns 7,981 shares of the medical research company’s stock worth $263,000 after purchasing an additional 229 shares during the period. Principal Financial Group Inc. raised its position in shares of VWR Corporation by 2.7% during the first quarter. Principal Financial Group Inc. now owns 17,339 shares of the medical research company’s stock worth $489,000 after purchasing an additional 450 shares during the period. Public Employees Retirement System of Ohio raised its position in shares of VWR Corporation by 3.4% during the first quarter. Public Employees Retirement System of Ohio now owns 31,762 shares of the medical research company’s stock worth $896,000 after purchasing an additional 1,031 shares during the period. Finally, Capital Insight Partners LLC raised its position in shares of VWR Corporation by 4.4% during the second quarter. Capital Insight Partners LLC now owns 46,748 shares of the medical research company’s stock worth $1,543,000 after purchasing an additional 1,962 shares during the period.
About VWR Corporation
VWR Corporation is a provider of product and service solutions to laboratory and production customers. The Company offers a portfolio of branded and private label laboratory products, services and solutions to the life science, general research and applied markets. The Company operates in two segments: Americas and EMEA-APAC.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for VWR Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VWR Corporation and related companies with MarketBeat.com's FREE daily email newsletter.